Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 222,885,964 papers from all fields of science
Search
Sign In
Create Free Account
TAP-144
Known as:
TAP 144
, TAP144
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
2 relations
Broader (2)
Leuprolide
Leuprolide Acetate
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
2018
2018
Usefulness of pharmacokinetic/efficacy analysis of an investigational kisspeptin analog, TAK‐448, in quantitatively evaluating anti‐tumor growth effect in the rat VCaP androgen‐sensitive prostate…
K. Ishikawa
,
Akira Tanaka
,
Akifumi Kogame
,
Tatsuya Watanabe
,
Y. Tagawa
,
H. Matsui
European Journal of Pharmacology
2018
Corpus ID: 5042054
2002
2002
[Clinical effects of a 3-month formulation LH-RH agonist, TAP-144-SR (3M) in prostate cancer patients].
K. Koiso
,
H. Yamanaka
,
Kazuto Ito
,
Ryoji Yoshinaka
,
S. Uchida
,
K. Yokokawa
Hinyokika kiyo. Acta urologica Japonica
2002
Corpus ID: 43139641
TAP-144-SR (3M) is a 3-month sustained releasing injection of a super-active agonist of luteinizing hormone releasing hormone (LH…
Expand
2002
2002
[Clinical effects of a 3-month formulation LH-RH agonist, TAP-144-SR (3M) in prostate cancer patients].
K. Koiso
,
H. Akaza
,
+9 authors
K. Yokokawa
Hinyokika kiyo. Acta urologica Japonica
2002
Corpus ID: 40132485
A randomized, multicenter, double-blind, parallel-group study was conducted in order to evaluate the hormonal kinetics…
Expand
1996
1996
Protective effect of leuprolide acetate on 7,12-dimethylbenz(a)anthracene (DMBA)-induced mammary carcinogenesis in rats.
K. Inada
,
T. Tominaga
,
+4 authors
M. Ogawa
European Journal of Surgical Oncology
1996
Corpus ID: 30856404
1996
1996
Continuous stimulation of gonadotropin-releasing hormone (GnRH) receptors by GnRH agonist decreases pituitary GnRH receptor messenger ribonucleic acid concentration in immature female rats.
H. Sakakibara
,
M. Taga
,
M. Ikeda
,
K. Kurogi
,
H. Minaguchi
Endocrine journal
1996
Corpus ID: 2174450
Although it is well recognized that continuous administration of gonadotropin-releasing hormone agonist (GnRHa) induces pituitary…
Expand
1991
1991
Does a gonadotropin-releasing hormone analogue prevent cisplatin-induced spermatogenic impairment?
M. Nonomura
,
K. Okada
,
S. Hida
,
O. Yoshida
Urological research
1991
Corpus ID: 8162034
SummaryThe cytotoxic effect of cis-diamminedichloro-platinum II (cisplatin, CDDP) on spermatogenesis in BALB/C mice, and possible…
Expand
1990
1990
Endocrinological studies on TAP-144-SR, a sustained-release formulation of a potent GnRH agonist (D-Leu6-[des-Gly10-NH2]-GnRH ethylamide), in male rats.
K. Sudo
,
T. Masaki
,
K. Shiota
,
M. Kawase
,
T. Fujita
Endocrinologia Japonica
1990
Corpus ID: 26892725
The paradoxical effects of TAP-144-SR, a biodegradable sustained-release formulation of a potent GnRH agonist (TAP-144…
Expand
1989
1989
[Regulation of aromatase activity by gonadotropin-releasing hormone and its agonists in cultured rat granulosa cells].
S. Liang
,
Y. Taketani
,
T. Yano
,
M. Mizuno
Nihon Sanka Fujinka Gakkai zasshi
1989
Corpus ID: 23418752
The effects of Gn-RH and its agonists on the activity of aromatase were examined by means of a rat granulosa cell culture system…
Expand
1984
1984
Serum concentration patterns of an LHRH agonist, gonadotrophins and sex steroids after subcutaneous, vaginal, rectal and nasal administration of the agonist to pregnant rats.
I. Yamazaki
Journal of Reproduction and Fertility
1984
Corpus ID: 518109
A highly potent LHRH agonist, des-Gly10-[D-Leu6]-LHRH-ethylamide (TAP-144), was administered by subcutaneous, vaginal, rectal and…
Expand
1982
1982
Enhanced and reversed growth in vitro of a pregnancy-dependent mouse mammary tumor (TPDMT-4) by a gonadotropin-releasing hormone agonist analog.
A. Matsuzawa
,
T. Yamamoto
European Journal of Cancer and Clinical Oncology
1982
Corpus ID: 36677458
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE